Several other research firms also recently commented on RHK. Deutsche Bank AG set a €21.00 ($24.71) price objective on Rhoen Klinikum AG and gave the stock a neutral rating in a report on Wednesday, July 26th. Jefferies Group LLC set a €17.60 ($20.71) price objective on Rhoen Klinikum AG and gave the stock a sell rating in a report on Thursday, August 3rd. Commerzbank Ag set a €25.00 ($29.41) price objective on Rhoen Klinikum AG and gave the stock a neutral rating in a report on Tuesday, July 25th. DZ Bank AG reiterated a sell rating on shares of Rhoen Klinikum AG in a report on Monday, May 29th. Finally, Credit Suisse Group set a €24.40 ($28.71) price objective on Rhoen Klinikum AG and gave the stock a sell rating in a report on Friday. Three equities research analysts have rated the stock with a sell rating and five have assigned a hold rating to the stock. Rhoen Klinikum AG has a consensus rating of Hold and a consensus price target of €23.50 ($27.65).
Rhoen Klinikum AG (ETR RHK) traded up 0.296% during mid-day trading on Monday, hitting €26.771. 100 shares of the stock traded hands. Rhoen Klinikum AG has a 52-week low of €22.91 and a 52-week high of €27.51. The firm’s 50-day moving average is €25.99 and its 200 day moving average is €25.81. The firm has a market cap of €1.79 billion and a P/E ratio of 125.098.
TRADEMARK VIOLATION NOTICE: “Rhoen Klinikum AG (RHK) Given a €26.50 Price Target at Berenberg Bank” was first reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://www.themarketsdaily.com/2017/08/08/rhoen-klinikum-ag-rhk-given-a-26-50-price-target-at-berenberg-bank.html.
About Rhoen Klinikum AG
Receive News & Ratings for Rhoen Klinikum AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related companies with MarketBeat.com's FREE daily email newsletter.